Skip to main navigation Skip to search Skip to main content

Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles

  • Sean M. Davidson
  • , Chantal M. Boulanger*
  • , Elena Aikawa
  • , Lina Badimon
  • , Lucio Barile
  • , Christoph J. Binder
  • , Alain Brisson
  • , Edit Buzas
  • , Costanza Emanueli
  • , Felix Jansen
  • , Miroslava Katsur
  • , Romaric Lacroix
  • , Sai Kiang Lim
  • , Nigel Mackman
  • , Manuel Mayr
  • , Philippe Menasché
  • , Rienk Nieuwland
  • , Susmita Sahoo
  • , Kaloyan Takov
  • , Thomas Thum
  • Pieter Vader, Marca H. M. Wauben, Kenneth Witwer, Joost P. G. Sluijter
*Corresponding author for this work
  • University College London
  • INSERM U970, Paris, France
  • Harvard University
  • Autonomous University of Barcelona
  • Università della Svizzera italiana
  • Medical University of Vienna
  • Institut de Chimie et Biologie des Membranes et des Nano-objets (CBMN)
  • Semmelweis University
  • Imperial College London
  • University of Bonn
  • Aix-Marseille Université
  • Hôpital de la Conception
  • Agency for Science, Technology and Research, Singapore
  • National University of Singapore
  • University of North Carolina at Chapel Hill
  • British Heart Foundation
  • Hôpital européen Georges Pompidou
  • University Medical Center Utrecht
  • Icahn School of Medicine at Mount Sinai
  • Hannover Medical School
  • Fraunhofer Institute for Toxicology and Experimental Medicine
  • Utrecht University
  • Johns Hopkins University

Research output: Contribution to journalReview articleAcademicpeer-review

179 Downloads (Pure)

Abstract

Extracellular vesicles (EVs) are nanosized vesicles with a lipid bilayer that are released from cells of the cardiovascular system, and are considered important mediators of intercellular and extracellular communications. Two types of EVs of particular interest are exosomes and microvesicles, which have been identified in all tissue and body fluids and carry a variety of molecules including RNAs, proteins, and lipids. EVs have potential for use in the diagnosis and prognosis of cardiovascular diseases and as new therapeutic agents, particularly in the setting of myocardial infarction and heart failure. Despite their promise, technical challenges related to their small size make it challenging to accurately identify and characterize them, and to study EV-mediated processes. Here, we aim to provide the reader with an overview of the techniques and technologies available for the separation and characterization of EVs from different sources. Methods for determining the protein, RNA, and lipid content of EVs are discussed. The aim of this document is to provide guidance on critical methodological issues and highlight key points for consideration for the investigation of EVs in cardiovascular studies.
Original languageEnglish
Pages (from-to)45-63
Number of pages19
JournalCardiovascular research
Volume119
Issue number1
DOIs
Publication statusPublished - 1 Jan 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Biodistribution
  • Blood
  • Cardiovascular diseases
  • Exosomes
  • Extracellular vesicle composition
  • Heart
  • Microvesicles
  • Therapeutics

Fingerprint

Dive into the research topics of 'Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles'. Together they form a unique fingerprint.

Cite this